Wednesday, September 28, 2016

CO Zopiclone




CO Zopiclone may be available in the countries listed below.


Ingredient matches for CO Zopiclone



Eszopiclone

Zopiclone is reported as an ingredient of CO Zopiclone in the following countries:


  • Canada

International Drug Name Search

Posted by at No comments:
Labels:

Oleptro


Oleptro is a brand name of trazodone, approved by the FDA in the following formulation(s):


OLEPTRO (trazodone hydrochloride - tablet, extended release; oral)



  • Manufacturer: ANGELINI LLC

    Approval date: February 2, 2010

    Strength(s): 150MG [RLD], 300MG

Has a generic version of Oleptro been approved?


No. There is currently no therapeutically equivalent version of Oleptro available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Oleptro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
    Patent 6,607,748
    Issued: August 19, 2003
    Inventor(s): Vincent; Lenaerts & Roland Herwig Friedrich; Beck & Elsie; Van Bogaert & Francois; Chouinard & Reiner; Höpcke & Cyril; Désévaux
    The present invention relates to a novel form of cross-linked high amylose starch and processes for its manufacture. Such cross-linked high amylose starch is useful as an excipient in a controlled-release pharmaceutical formulation when compressed with pharmaceutical agent(s) in a tablet. Such cross-linked high amylose starch is prepared by (a) cross-linking and chemical modification of high amylose starch, (b) gelatinization, and (c) drying to obtain a powder of said controlled release excipient. In a preferred embodiment, such cross-linked high amylose starch is prepared in the following steps: (1) granular cross-linking and additional chemical modification (e.g., hydroxypropylation) of high-amylose starch; (2) thermal gelatinization of the starch from step (1); and (3) drying the starch from step (2) to yield a powder capable of being used as a controlled release excipient.
    Patent expiration dates:

    • June 29, 2020
      ✓ 
      Drug product




  • Trazodone composition for once a day administration
    Patent 7,829,120
    Issued: November 9, 2010
    Inventor(s): Gervais; Sonia & Smith; Damon & Rahmouni; Miloud & Contamin; Pauline & Ouzerourou; Rachid & Ma; My Linh & Ferrada; Angela & Soulhi; Fouzia
    Assignee(s): Labopharm Inc.
    Labopharm Europe Limited
    Labopharm (Barbados) Limited
    The invention relates to a once a day formulation of trazodone or a trazodone derivative. The formulation contains trazodone or a trazodone derivative and a controlled release excipient so that, once administered orally, the trazodone or the trazodone derivative is maintained at a therapeutic plasma concentration from at least 1 hour to at least 24 hours after initial administration. After administration, the initial therapeutic action takes effect within the first hour and lasts at least about 24 hours. This therapeutic effect remains relatively and substantially stable for the remaining period of 24 hours. The formulations can be used for treating depression and/or sleeping disorders.
    Patent expiration dates:

    • March 27, 2027
      ✓ 
      Patent use: METHOD OF TREATING DEPRESSION
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • February 2, 2013 - NEW DOSAGE FORM

See also...

  • Oleptro Consumer Information (Drugs.com)
  • Oleptro Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Oleptro Consumer Information (Cerner Multum)
  • Oleptro Advanced Consumer Information (Micromedex)
  • Trazodone Consumer Information (Drugs.com)
  • Trazodone Consumer Information (Wolters Kluwer)
  • Trazodone Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Trazodone Consumer Information (Cerner Multum)
  • Trazodone Advanced Consumer Information (Micromedex)
  • Trazodone Hydrochloride AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

DermOtic Oil


DermOtic Oil is a brand name of fluocinolone otic, approved by the FDA in the following formulation(s):


DERMOTIC (fluocinolone acetonide - oil/drops; otic)



  • Manufacturer: HILL DERMAC

    Approval date: November 9, 2005

    Strength(s): 0.01% [RLD][AT]

Has a generic version of DermOtic Oil been approved?


Yes. The following products are equivalent to DermOtic Oil:


fluocinolone acetonide oil/drops; otic



  • Manufacturer: IDENTI PHARMS INC

    Approval date: October 17, 2011

    Strength(s): 0.01% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DermOtic Oil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with DermOtic Oil.

See also...

  • DermOtic Drops Consumer Information (Wolters Kluwer)
  • Fluocinolone Drops Consumer Information (Wolters Kluwer)
Posted by at No comments:
Labels:

Myleran


Myleran is a brand name of busulfan, approved by the FDA in the following formulation(s):


MYLERAN (busulfan - tablet; oral)



  • Manufacturer: ASPEN GLOBAL

    Approved Prior to Jan 1, 1982

    Strength(s): 2MG [RLD]

Has a generic version of Myleran been approved?


No. There is currently no therapeutically equivalent version of Myleran available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Myleran. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Myleran.

See also...

  • Myleran Consumer Information (Wolters Kluwer)
  • Myleran Consumer Information (Cerner Multum)
  • Busulfan Consumer Information (Wolters Kluwer)
  • Busulfan Tablet Consumer Information (Wolters Kluwer)
  • Busulfan Consumer Information (Cerner Multum)
  • Busulfan Intravenous Advanced Consumer Information (Micromedex)
  • Busulfan AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Microzide


Microzide is a brand name of hydrochlorothiazide, approved by the FDA in the following formulation(s):


MICROZIDE (hydrochlorothiazide - capsule; oral)



  • Manufacturer: WATSON LABS

    Approval date: December 27, 1996

    Strength(s): 12.5MG [RLD][AB]

Has a generic version of Microzide been approved?


Yes. The following products are equivalent to Microzide:


hydrochlorothiazide capsule; oral



  • Manufacturer: ALEMBIC PHARMS LTD

    Approval date: November 30, 2010

    Strength(s): 12.5MG [AB]


  • Manufacturer: APOTEX

    Approval date: May 16, 2008

    Strength(s): 12.5MG [AB]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: September 18, 2007

    Strength(s): 12.5MG [AB]


  • Manufacturer: IPCA LABS LTD

    Approval date: April 2, 2009

    Strength(s): 12.5MG [AB]


  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: July 13, 2005

    Strength(s): 12.5MG [AB]


  • Manufacturer: JUBILANT CADISTA

    Approval date: February 11, 2008

    Strength(s): 12.5MG [AB]


  • Manufacturer: LANNETT HOLDINGS INC

    Approval date: January 27, 2012

    Strength(s): 12.5MG [AB]


  • Manufacturer: MYLAN

    Approval date: January 28, 2000

    Strength(s): 12.5MG [AB]


  • Manufacturer: UNICHEM

    Approval date: January 19, 2010

    Strength(s): 12.5MG [AB]


  • Manufacturer: VINTAGE PHARMS

    Approval date: September 17, 2002

    Strength(s): 12.5MG [AB]


  • Manufacturer: WEST WARD

    Approval date: November 26, 2007

    Strength(s): 12.5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Microzide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Microzide.

See also...

  • Microzide Consumer Information (Wolters Kluwer)
  • Microzide Consumer Information (Cerner Multum)
  • Microzide Advanced Consumer Information (Micromedex)
  • HCTZ Consumer Information (Drugs.com)
  • Hydrochlorothiazide Consumer Information (Drugs.com)
  • Hydrochlorothiazide Consumer Information (Wolters Kluwer)
  • Hydrochlorothiazide Capsules Consumer Information (Wolters Kluwer)
  • Hydrochlorothiazide Solution Consumer Information (Wolters Kluwer)
  • Hydrochlorothiazide Consumer Information (Cerner Multum)
  • Hydrocot Advanced Consumer Information (Micromedex)
  • Zide Advanced Consumer Information (Micromedex)
  • Hydrochlorothiazide Advanced Consumer Information (Micromedex)
  • Hydrochlorothiazide AHFS DI Monographs (ASHP)
Posted by at No comments:
Labels:

Adrenaline Hydrochloride Injection




Adrenaline Hydrochloride Injection may be available in the countries listed below.


Ingredient matches for Adrenaline Hydrochloride Injection



Epinephrine

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Adrenaline Hydrochloride Injection in the following countries:


  • Australia

International Drug Name Search

Posted by at No comments:
Labels:

Biopatch




In the US, Biopatch (chlorhexidine topical) is a member of the following drug classes: antiseptic and germicides, mouth and throat products and is used to treat Gingivitis, Mucositis and Periodontitis.

US matches:

  • Biopatch

  • Biopatch w/Chlorhexidine Gluconate

Ingredient matches for Biopatch



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Biopatch in the following countries:


  • United States

International Drug Name Search

Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)